These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 24379917)

  • 21. Childhood obesity in Asian Indians: a burgeoning cause of insulin resistance, diabetes and sub-clinical inflammation.
    Bhardwaj S; Misra A; Khurana L; Gulati S; Shah P; Vikram NK
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():172-5. PubMed ID: 18296330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acanthosis nigricans in childhood: A cutaneous marker that should not be underestimated, especially in obese children.
    Maguolo A; Maffeis C
    Acta Paediatr; 2020 Mar; 109(3):481-487. PubMed ID: 31560795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis, treatment and prevention of type 2 diabetes mellitus in children and adolescents.
    Serbis A; Giapros V; Kotanidou EP; Galli-Tsinopoulou A; Siomou E
    World J Diabetes; 2021 Apr; 12(4):344-365. PubMed ID: 33889284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From Metabolic Syndrome to Type 2 Diabetes in Youth.
    Iafusco D; Franceschi R; Maguolo A; Guercio Nuzio S; Crinò A; Delvecchio M; Iughetti L; Maffeis C; Calcaterra V; Manco M
    Children (Basel); 2023 Mar; 10(3):. PubMed ID: 36980074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 2 diabetes mellitus in children and adolescents.
    Marcovecchio M; Mohn A; Chiarelli F
    J Endocrinol Invest; 2005 Oct; 28(9):853-63. PubMed ID: 16370570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The obesity syndrome and acanthosis nigricans. Acanthosis nigricans is a common cosmetic problem providing epidemiological clues to the obesity syndrome, the insulin-resistance syndrome, the thrifty metabolism, dyslipidaemia, hypertension and diabetes mellitus type II.
    Maitra SK; Rowland Payne CM
    J Cosmet Dermatol; 2004 Dec; 3(4):202-10. PubMed ID: 17166107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for medication-induced diabetes and type 2 diabetes.
    Amed S; Dean H; Sellers EA; Panagiotopoulos C; Shah BR; Booth GL; Laubscher TA; Dannenbaum D; Hadjiyannakis S; Hamilton JK
    J Pediatr; 2011 Aug; 159(2):291-6. PubMed ID: 21353243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [From obesity to type 2 diabetes in children and adolescents].
    Theintz G
    Rev Med Suisse; 2005 Feb; 1(7):477-80. PubMed ID: 15790014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [(Pre)type 2 diabetes and MODY: pediatric diabetology future].
    Mouraux T; Dorchy H
    Rev Med Brux; 2010; 31(2 Suppl):S113-23. PubMed ID: 21812223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of type 2 diabetes mellitus in children and adolescents.
    Springer SC; Silverstein J; Copeland K; Moore KR; Prazar GE; Raymer T; Shiffman RN; Thaker VV; Anderson M; Spann SJ; Flinn SK;
    Pediatrics; 2013 Feb; 131(2):e648-64. PubMed ID: 23359584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediabetes and type 2 diabetes in youth: an emerging epidemic disease?
    Cali AM; Caprio S
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):123-7. PubMed ID: 18316946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ketoacidosis Onset of Diabetes on a Patient with Normal C-Peptide Value.
    Novac CN; Boboc AA; Nastac C; Balgradean M; Radulian G
    Maedica (Bucur); 2021 Jun; 16(2):320-324. PubMed ID: 34621360
    [No Abstract]   [Full Text] [Related]  

  • 33. Type 2 diabetes mellitus: a review of current trends.
    Olokoba AB; Obateru OA; Olokoba LB
    Oman Med J; 2012 Jul; 27(4):269-73. PubMed ID: 23071876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiology of type 2 diabetes mellitus in youth: the evolving chameleon.
    Tfayli H; Arslanian S
    Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):165-74. PubMed ID: 19466209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 2 diabetes mellitus in children and adolescent: an Indonesian perspective.
    Pulungan AB; Afifa IT; Annisa D
    Ann Pediatr Endocrinol Metab; 2018 Sep; 23(3):119-125. PubMed ID: 30286566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incretin-based therapies for type 2 diabetes mellitus: a review of direct comparisons of efficacy, safety and patient satisfaction.
    Russell S
    Int J Clin Pharm; 2013 Apr; 35(2):159-72. PubMed ID: 23263796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type 2 diabetes mellitus in children and adolescents: a review from a European perspective.
    Kiess W; Böttner A; Raile K; Kapellen T; Müller G; Galler A; Paschke R; Wabitsch M
    Horm Res; 2003; 59 Suppl 1():77-84. PubMed ID: 12566725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence of the metabolic syndrome and type 2 diabetes mellitus in children and adolescents.
    Molnár D
    Int J Obes Relat Metab Disord; 2004 Nov; 28 Suppl 3():S70-4. PubMed ID: 15543223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of Hypertension and Albuminuria in Pediatric Type 2 Diabetes: A Systematic Review and Meta-analysis.
    Cioana M; Deng J; Hou M; Nadarajah A; Qiu Y; Chen SSJ; Rivas A; Banfield L; Chanchlani R; Dart A; Wicklow B; Alfaraidi H; Alotaibi A; Thabane L; Samaan MC
    JAMA Netw Open; 2021 Apr; 4(4):e216069. PubMed ID: 33929524
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.